Roche recently announced that its product Evrysdi (risdiplam) was recommended for approval for the treatment of spinal muscular atrophy (SMA) in patients two months of age and older by the...
On 14 December, the US Food and Drug Administration (FDA) approved a shorter two-hour infusion time for Roche’s Ocrevus (ocrelizumab)...
uniQure presented positive data from its pivotal Phase III HOPE-B trial in haemophilia B for its novel gene therapy EtranaDez...
The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the...
© Copyright Verdict Media Limited 2021
